Community Outreach Core

项目总结 社区外展核心 联席领导：谭茵，医学博士，硕士，HC联席领导：叶明进博士 伊夫林·冈萨雷斯，MA Marilyn A.Fraser，医学博士 长期以来，癌症筛查的早期检测一直被认为是减少癌症的有效工具 负担；然而，未得到充分服务的种族和族裔少数群体继续利用这些服务 不成比例。例如，乳腺癌(BC)和结直肠癌(CRC)筛查仍然很低 在非洲裔美国人(AA)、亚太裔美国人(APA)和西班牙裔美国人(HA)人群中。这些 此前存在的差距因新冠肺炎大流行而进一步加剧。实施量身定做的文化 循证癌症筛查干预措施，通过以下方式促进BC和CRC筛查的重新参与 在服务不足的AA、APA和HA社区中，社区参与和能力建设至关重要。在……里面 此外，高达10%的癌症可能是由遗传基因引起的。最近几天，遗传/基因组 癌症风险评估和治疗检测已被广泛用于临床癌症早期检测， 诊断和治疗。然而，在少数族裔人群中，检测率仍然很低，因为他们 经常面临健康的社会决定因素的挑战和系统性障碍，如语言障碍、低 健康素养、对基因/基因组检测的认识和知识不足以及医学上的不信任。 克服这些障碍以提高认识和增加检测至关重要。因此，在成功的基础上， 我们当前的供资周期(2018-2023年)与TUfccc/HC伙伴关系调查人员和 在PA-NJ-纽约市(PNN)地区的社区合作伙伴，COC的目标是使用社区参与 在获取循证数据方面解决系统性障碍和促进包容性的方法 在服务不足和研究不足的AA、APA和HA人群中开展癌症筛查和基因检测的干预措施 人口。具体地说，拟议的COC的总体目标是：(1)让社区参与癌症 在我们服务的社区内推广和支持癌症筛查计划，(2)支持U54 通过建立和维持可持续发展的社区癌症研究的研究人员/教育机构/受训人员 CBPR基础设施；以及(3)促进和加强TUfccc/HC之间的双向交流 调查人员和社区。

PROJECT SUMMARY Community Outreach Core TUFCCC Co-Leader: Yin Tan, MD, MPH HC Co-Leader: Ming-Chin Yeh, PhD Evelyn Gonzalez, MA Marilyn A. Fraser, MD Early detection for cancer screening has long been established as an effective tool to reducing the cancer burden; however, utilization of these services by underserved racial and ethnic minorities (UREM) continues to be disproportionate. For example, breast cancer (BC) and colorectal cancer (CRC) screening remains low among African American (AA), Asian Pacific American (APA), and Hispanic American (HA) populations. These pre-existing disparities were further exacerbated by the COVID-19 pandemic. Implementing culturally tailored evidence-based cancer screening interventions to foster BC and CRC screening re-engagement through community engagement and capacity building in underserved AA, APA, and HA communities is crucial. In addition, up to 10% of all cancers may be caused by inherited genetic profiles. In recent days, genetic/genomic testing for cancer risk assessment and treatment has been widely utilized clinically for cancer early detection, diagnosis and treatment. However, the testing rates remain low in racial/ethnical minority populations as they often face challenges and systemic barriers of social determinants of health, such as language barriers, low health literacy, poor awareness and knowledge about genetic/genomic testing, and medical mistrust. Overcoming these barriers to raise awareness and to increase testing is vital. Thus, building on the success of our current funding cycle (2018-2023) in collaboration with TUFCCC/HC Partnership investigators and community partners in the PA-NJ-New York City (PNN) region, the COC aims to use community-engaged approach to addressing systemic barriers and promoting inclusion in accessing evidence-based interventions on cancer screenings and genetic testing among underserved and understudied AA, APA and HA populations. Specifically, the overall goals of the proposed COC are to: (1) engage the community in cancer outreach and sustain cancer screening programs within the communities we serve, (2) support U54 investigators/ESIs/Trainees on community-based cancer research through building and maintaining sustainable CBPR infrastructure; and (3) facilitate and enhance bi-directional communication between TUFCCC/HC investigators and community.